Financial markets

DGAP-News: ENCAVIS AG

Friday, May 14, 2021 - 7:00am

This will also be offered again as scrip dividend in shares or for cash distribution.\nEncavis AG (Prime Standard; ISIN: DE0006095003; ticker symbol: ECV) is a producer of electricity from renewable energies listed on the MDAX of Deutsche B\xc3\xb6rse AG.

Key Points: 
  • This will also be offered again as scrip dividend in shares or for cash distribution.\nEncavis AG (Prime Standard; ISIN: DE0006095003; ticker symbol: ECV) is a producer of electricity from renewable energies listed on the MDAX of Deutsche B\xc3\xb6rse AG.
  • The Encavis Group\'s total generation capacity is currently around 2.8 gigawatts (GW), corresponding to a CO2 avoidance of 1.26 million tonnes p.a.
  • Within the Encavis Group, Encavis Asset Management AG offers fund services to institutional investors.\nENCAVIS is a signatory of the UN Global Compact as well as of the UN PRI network.
  • Encavis AG\'s environmental, social and governance performance has been awarded by two of the world\'s leading ESG rating agencies.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm

Friday, May 14, 2021 - 3:00am

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • Additional information about each case can be found at the link provided.\nPeloton provides interactive fitness products such as the Peloton Bike and the Peloton Tread+ and Tread, which include touchscreens that stream live and on-demand classes.
  • is a nationally recognized law firm with offices in New York, California, and South Carolina.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Vera Therapeutics Announces Pricing of Initial Public Offering

Friday, May 14, 2021 - 1:52am

b'SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (\xe2\x80\x9cVera\xe2\x80\x9d), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its initial public offering of 4,350,000 shares of its Class A common stock at a price to the public of $11.00 per share.

Key Points: 
  • b'SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (\xe2\x80\x9cVera\xe2\x80\x9d), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its initial public offering of 4,350,000 shares of its Class A common stock at a price to the public of $11.00 per share.
  • The gross proceeds to Vera from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $47.85 million.
  • All of the shares are being offered by Vera.
  • This offering is being made only by means of a written prospectus, forming a part of the effective registration statement.

Digital Brands Group, Inc. Announces Pricing of $10.0 Million Initial Public Offering and Nasdaq Listing

Friday, May 14, 2021 - 1:58am

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 361,445 shares and 361,445 warrants at the public offering price less the underwriting discounts and commissions.

Key Points: 
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 361,445 shares and 361,445 warrants at the public offering price less the underwriting discounts and commissions.
  • Manatt, Phelps & Phillips, LLP represented Digital Brands and Nelson Mullins Riley & Scarborough LLP acted for Kingswood.\nThe Securities and Exchange Commission ("SEC") declared effective a registration statement on Form S-1 (File No.
  • The Company has strategically expanded into an omnichannel brand offering these styles and content not only on-line but at selected wholesale and retail storefronts.
  • No assurance can be given that the offering will be completed on the terms described, or at all.

Fluor Announces Pricing of Upsized Convertible Preferred Stock Offering

Friday, May 14, 2021 - 12:04am

b'Fluor Corporation (NYSE: FLR) (the \xe2\x80\x9cCompany\xe2\x80\x9d or \xe2\x80\x9cFluor\xe2\x80\x9d) announced today that it has priced its previously announced private placement of 525,000 shares of a newly created series of convertible preferred stock, to be designated as Series A 6.50% Cumulative Perpetual Convertible Preferred Stock (the \xe2\x80\x9cPreferred Stock\xe2\x80\x9d).

Key Points: 
  • b'Fluor Corporation (NYSE: FLR) (the \xe2\x80\x9cCompany\xe2\x80\x9d or \xe2\x80\x9cFluor\xe2\x80\x9d) announced today that it has priced its previously announced private placement of 525,000 shares of a newly created series of convertible preferred stock, to be designated as Series A 6.50% Cumulative Perpetual Convertible Preferred Stock (the \xe2\x80\x9cPreferred Stock\xe2\x80\x9d).
  • The Company has also increased the size of the offering to 525,000 shares from the previously announced 450,000 shares and has granted the initial purchasers of the Preferred Stock a 30-day option to purchase up to an additional 75,000 in shares of Preferred Stock.
  • The Company intends to use the net proceeds from this offering to redeem or repay outstanding indebtedness and for general corporate purposes.
  • The offering is expected to close on May 18, 2021, subject to customary closing conditions.\nThe Preferred Stock does not have a maturity date.

Kalkine Pty Limited Launches 'Global Commodities Technical Analysis Research'

Friday, May 14, 2021 - 12:00am

b"SYDNEY, May 14, 2021 /PRNewswire/ -- Kalkine is pleased to announce the launch of its 'Global Commodity Technical Analysis Research', a technical analysis-driven insight on Global Commodities.\nKalkine's Global Commodities research considers diverse opportunities over a short timespan with scale of risk appetite and financial flexibility being looked at.This research covers agricultural and non-agricultural commodities including Gold, Silver, Copper, Aluminium, Lead, Nickel, Crude Oil, Zinc, Natural Gas, Sugar, Soybean, Wheat, etc.

Key Points: 
  • b"SYDNEY, May 14, 2021 /PRNewswire/ -- Kalkine is pleased to announce the launch of its 'Global Commodity Technical Analysis Research', a technical analysis-driven insight on Global Commodities.\nKalkine's Global Commodities research considers diverse opportunities over a short timespan with scale of risk appetite and financial flexibility being looked at.This research covers agricultural and non-agricultural commodities including Gold, Silver, Copper, Aluminium, Lead, Nickel, Crude Oil, Zinc, Natural Gas, Sugar, Soybean, Wheat, etc.
  • trading on the exchanges including COMEX, LME, NYMEX, ICE, and CBOT.
  • This research will be available on Kalkine's New Zealand platform as well as the newly launched US Platform - Kalkine Equities LLC.\nGenerally, prudent investors ponder upon whether to consider Commodities or Equities during the time of inflation and economic uncertainties.\nSelecting commodities is a challenging taskamid highly volatile financial markets.
  • The commodity market movements depend on the evolving fundamentals like periodic inventory, supply and demand, production levels, and macroeconomic factors including socio-political stability, inflation, currency, and interest rates, etc.

Flora Growth Corp. Announces Closing of Initial Public Offering

Thursday, May 13, 2021 - 10:13pm

b'TORONTO, May 13, 2021 (GLOBE NEWSWIRE) -- Flora Growth Corp. (NASDAQ: FLGC) (\xe2\x80\x9cFlora\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today announced the closing of its initial public offering of 3,333,333 of its common shares.\nOn May 11, 2021, the Company\xe2\x80\x99s common shares commenced trading on the Nasdaq Capital Market under the ticker symbol \xe2\x80\x9cFLGC".

Key Points: 
  • b'TORONTO, May 13, 2021 (GLOBE NEWSWIRE) -- Flora Growth Corp. (NASDAQ: FLGC) (\xe2\x80\x9cFlora\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today announced the closing of its initial public offering of 3,333,333 of its common shares.\nOn May 11, 2021, the Company\xe2\x80\x99s common shares commenced trading on the Nasdaq Capital Market under the ticker symbol \xe2\x80\x9cFLGC".
  • The initial public offering was priced at the high end of the proposed price range at US$5.00\xc2\xa0per share to the public for a total of\xc2\xa0US$16,666,665\xc2\xa0of gross proceeds to the Company.\nBoustead Securities, LLC acted as the sole underwriter for the offering (the \xe2\x80\x9cUnderwriter\xe2\x80\x9d) with MKM Partners acting as co-Manager.
  • As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices.
  • By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive.

Decibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate Update

Thursday, May 13, 2021 - 10:05pm

In early 2021, we announced encouraging preclinical results on our lead gene therapy program, DB-OTO, for the treatment of people with otoferlin deficiency.

Key Points: 
  • In early 2021, we announced encouraging preclinical results on our lead gene therapy program, DB-OTO, for the treatment of people with otoferlin deficiency.
  • We also established a critical cGMP manufacturing and development relationship with Catalent,\xe2\x80\x9d said Laurence Reid, Ph.D., Chief Executive Officer of Decibel.
  • Additionally, Decibel completed its Initial Public Offering (IPO) of 7,662,000 shares of common stock at a public offering price of $18.00 per share.
  • However, while Decibel may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

Eloxx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Thursday, May 13, 2021 - 9:01pm

b"WALTHAM, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (the \xe2\x80\x9cCompany\xe2\x80\x9d) (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it has commenced an underwritten public offering of shares of its common stock.

Key Points: 
  • b"WALTHAM, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (the \xe2\x80\x9cCompany\xe2\x80\x9d) (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it has commenced an underwritten public offering of shares of its common stock.
  • In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock at the public offering price, less underwriting discounts and commissions.\nB.
  • Riley Securities, Inc. is acting as sole-book running manager for the offering.
  • The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.

Monaker Group Announces Proposed Public Offering of Common Stock

Thursday, May 13, 2021 - 9:05pm

b'Sunrise, FL, May 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Monaker Group, Inc. (NASDAQ: MKGI), a technology solutions company focused on building a digital business ecosystem that caters to and ties together digital advertisers, consumers, video gamers and travelers, today announced that it has commenced an underwritten public offering of its common stock.

Key Points: 
  • b'Sunrise, FL, May 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Monaker Group, Inc. (NASDAQ: MKGI), a technology solutions company focused on building a digital business ecosystem that caters to and ties together digital advertisers, consumers, video gamers and travelers, today announced that it has commenced an underwritten public offering of its common stock.
  • All of the shares in the offering are being offered by Monaker.
  • In addition, Monaker expects to grant the underwriters a 45-day option to purchase up to an additional 15% of shares of its common stock on the same terms and conditions.
  • A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering has been filed with the SEC.